Skip to Main Content

Paper Details

Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting.
Cell Metab
37
2022
liver disease, liver diseases
Author NameAffiliation
Aki S HavulinnaFinnish Institute for Health and Welfare, Finland Institute of Molecular Medicine Finland, University of Helsinki
Qiyun ZhuUniversity of California
Karin VerspoorUniversity of Melbourne, RMIT University
Karin VerspoorUniversity of Melbourne, RMIT University
Pekka JousilahtiFinnish Institute for Health and Welfare
Yoshiki V??zquez-BaezaCenter for Microbiome Innovation, University of California
Rohit LoombaNAFLD Research Center, University of California
Veikko SalomaaFinnish Institute for Health and Welfare
Michael InouyeBaker Heart and Diabetes Institute, Melbourne Medical School, The University of Melbourne, University of Cambridge, UK British Heart Foundation Cardiovascular Epidemiology Unit, UK British Heart Foundation Centre of Research Excellence, UK The Alan Turing Institute
  • 1 - 9

Datasets